These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 23616135)
21. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial. Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675 [TBL] [Abstract][Full Text] [Related]
22. Management and outcome of recurrent well-differentiated thyroid carcinoma. Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757 [TBL] [Abstract][Full Text] [Related]
23. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data. Kim WG; Kim TY; Kim TH; Jang HW; Jo YS; Park YJ; Kim SW; Kim WB; Shong M; Park DJ; Chung JH; Shong YK; Cho BY Korean J Intern Med; 2014 May; 29(3):325-33. PubMed ID: 24851067 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and prognostic analysis of follicular thyroid carcinoma in a single institute over a 15-year period. Yu XF; Wang WB; Teng XD; Wang HY; Chen X; Wang HH; Ma ZM; Fahey TJ; Teng LS Eur J Surg Oncol; 2014 Jul; 40(7):869-74. PubMed ID: 24613740 [TBL] [Abstract][Full Text] [Related]
25. Low-risk differentiated thyroid cancer: the need for selective treatment. Shaha AR; Shah JP; Loree TR Ann Surg Oncol; 1997 Jun; 4(4):328-33. PubMed ID: 9181233 [TBL] [Abstract][Full Text] [Related]
26. The treatment and prognosis of Hürthle cell follicular thyroid carcinoma compared with its non-Hürthle cell counterpart. Haigh PI; Urbach DR Surgery; 2005 Dec; 138(6):1152-7; discussion 1157-8. PubMed ID: 16360403 [TBL] [Abstract][Full Text] [Related]
27. Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size. Meixner M; Hellmich M; Dietlein M; Kobe C; Schicha H; Schmidt M Nuklearmedizin; 2013; 52(3):71-80. PubMed ID: 23483137 [TBL] [Abstract][Full Text] [Related]
28. [Operation strategy for follicular thyroid carcinoma]. Wu YS; Wang XD; Zhang WC Ai Zheng; 2008 Feb; 27(2):170-3. PubMed ID: 18279615 [TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution. Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082 [TBL] [Abstract][Full Text] [Related]
31. Recurrence and mortality in patients with differentiated thyroid carcinoma. Noguchi M; Yagi H; Earashi M; Kinoshita K; Miyazaki I; Mizukami Y Int Surg; 1995; 80(2):162-6. PubMed ID: 8530235 [TBL] [Abstract][Full Text] [Related]
32. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Haq M; Harmer C Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067 [TBL] [Abstract][Full Text] [Related]
33. Prognostic factors of insular versus papillary/follicular thyroid carcinoma. Falvo L; Catania A; D'Andrea V; Grilli P; D'Ercole C; De Antoni E Am Surg; 2004 May; 70(5):461-6. PubMed ID: 15156957 [TBL] [Abstract][Full Text] [Related]
34. Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma. Sugino K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Uruno T; Akaishi J; Kameyama K; Ito K Thyroid; 2011 Jul; 21(7):751-7. PubMed ID: 21615311 [TBL] [Abstract][Full Text] [Related]
36. Follicular and Hurthle cell carcinomas of the thyroid: a comparative study. Evans HL; Vassilopoulou-Sellin R Am J Surg Pathol; 1998 Dec; 22(12):1512-20. PubMed ID: 9850177 [TBL] [Abstract][Full Text] [Related]
37. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population. Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534 [TBL] [Abstract][Full Text] [Related]
39. Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients. Kuo EJ; Roman SA; Sosa JA Surgery; 2013 Dec; 154(6):1246-53; discussion 1253-4. PubMed ID: 23993409 [TBL] [Abstract][Full Text] [Related]
40. [Follicular carcinoma and Hürthle cell tumor of the thyroid]. Miccoli P; Arganini M Chir Ital; 1994; 46(4):29-32. PubMed ID: 7882439 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]